Key result
Systemic heparinization is linked to ~80% lower intracardiac thrombus risk during peripheral VA-ECMO.
Why the study?
Intracardiac thrombus is a potentially life-threatening complication of peripheral V-A or V-AV ECMO, yet its clinical predictors remain poorly defined, limiting risk stratification.
What clinical factors (such as LVEF, pulse pressure, and systemic heparinization) are associated with intracardiac thrombus during peripheral V-A and V-AV ECMO support?
Cohort (n=638)
No
What clinical factors (such as LVEF, pulse pressure, and systemic heparinization) are associated with intracardiac thrombus during peripheral V-A and V-AV ECMO support?
Answers are grounded in this paper and cite their sources.
Identifies LVEF (<35%), low day 1 pulse pressure, and absence of systemic heparinization as independent predictors of intracardiac thrombus during peripheral V-A/V-AV ECMO, guiding targeted imaging surveillance.
Introduction Intracardiac thrombus (ICT) is an uncommon but potentially life-threatening complication of peripheral venoarterial (V-A) or venovenoarterial (V-AV) extracorporeal membrane oxygenation (ECMO). However, clinical predictors of ICT remain poorly defined, limiting risk stratification. Methods This single-center retrospective cohort study included 638 adults who underwent 671 consecutive episodes of peripheral V-A/V-AV ECMO between 2021 and 2025. Factors associated with ICT were evaluated using cause-specific Cox regression, with ECMO discontinuation without ICT treated as a competing event. Restricted cubic splines were used to assess nonlinearity in continuous predictors. A secondary analysis compared ICT cases managed surgically and nonsurgically. Results ICT was detected in 58 ECMO episodes (8.6%). In multivariable analysis, left ventricular ejection fraction (LVEF; adjusted hazard ratio [aHR], 0.98 per 1% increase; 95% confidence interval [CI], 0.96–1.00; p = 0.028), day 1 pulse pressure (aHR, 0.98 per 1 mmHg increase; 95% CI, 0.96–1.00; p = 0.034), and systemic heparinization (aHR, 0.20; 95% CI, 0.11–0.39; p < 0.001) were independently associated with a lower hazard of ICT. The association between LVEF and ICT was nonlinear ( p = 0.033): risk was low at LVEF values above approximately 35% and increased sharply below this level. The association with pulse pressure was linear. Short-term outcomes did not differ between surgical and nonsurgical management. Conclusions During peripheral V-A/V-AV ECMO, ICT was independently associated with impaired cardiac function, low pulsatility, and the absence of systemic heparinization. Assessment of LVEF, initial pulse pressure, and anticoagulation status may help identify patients who warrant closer imaging surveillance.
No takes yet. Share an insight, caveat, or question.
Jung et al. (2026) conducted a cohort in Peripheral venoarterial (V-A) or venovenoarterial (V-AV) extracorporeal membrane oxygenation (ECMO) support (n=638). Systemic heparinization, higher LVEF, and higher day 1 pulse pressure vs. Absence of systemic heparinization, lower LVEF, and lower pulse pressure was evaluated on Intracardiac thrombus (ICT) (aHR 0.20, 95% CI 0.11-0.39, p=<0.001). Systemic heparinization, higher LVEF, and higher day 1 pulse pressure independently reduced intracardiac thrombus risk during peripheral V-A/V-AV ECMO.
Synapse has enriched 10 related papers. Consider them for comparative context: